Cargando…
Design and Synthesis of Covalent Inhibitors of FabA
[Image: see text] There is an urgent need for the development of new therapeutics with novel modes of action to target Gram-negative bacterial infections, due to resistance to current drugs. Previously, FabA, an enzyme in the bacterial type II fatty acid biosynthesis pathway, was identified as a pot...
Autores principales: | Martin, James S., Mackenzie, Claire J., Lin, De, Homeyer, Nadine, Gray, David W., Zuccotto, Fabio, Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099128/ https://www.ncbi.nlm.nih.gov/pubmed/37065080 http://dx.doi.org/10.1021/acsomega.2c08031 |
Ejemplares similares
-
A Substrate Mimic Allows High-Throughput Assay of the FabA Protein and Consequently the Identification of a Novel Inhibitor of Pseudomonas aeruginosa FabA
por: Moynié, Lucile, et al.
Publicado: (2016) -
Characterising covalent warhead reactivity
por: Martin, James S., et al.
Publicado: (2019) -
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors
por: Vazquez‐Rodriguez, Saleta, et al.
Publicado: (2018) -
Analysis of the Plasmid-Based ts-Mutant ΔfabA/pTS-fabA Reveals Its Lethality under Aerobic Growth Conditions That Is Suppressed by Mild Overexpression of desA at a Restrictive Temperature in Pseudomonas aeruginosa
por: Tian, Liyan, et al.
Publicado: (2023) -
A platform for target prediction of phenotypic screening hit molecules
por: Homeyer, Nadine, et al.
Publicado: (2020)